Episodes
-
Ahead of World Cancer Day on 4 February and the new campaign, ‘United by Unique,’ focusing on people-centred care, this episode of Let’s Talk Cancer highlights "Rewriting Cancer," a series of short films produced by BBC StoryWorks Commercial Productions for UICC. These films feature the experiences of people with cancer, their loved ones, caregivers, medical professionals, and volunteers worldwide. The series aims to dispel myths and highlight advancements in cancer prevention, diagnosis, treatment, and supportive care. With Gemma Jennings, Vice President at BBC StoryWorks, and James Waddington from the American Cancer Society, a prostate cancer survivor and advocate for early screening.
Hosted on Acast. See acast.com/privacy for more information.
-
Antimicrobial resistance, also known as AMR or drug resistance, is among the top 10 public health threats facing humanity, according to the World Health Organization.
Antimicrobial resistance happens when the medicines, including antiotics, are no longer able to fight infections from bacteria, fungi, viruses and parasites.
For cancer patients, the situation is particularly concerning. They have particularly weak immune systems due to the cancer treatment, such as chemotherapy, they are receiving and are therefore more prone to infections. As many as 1 in 5 cancer patients undergoing treatment are hospitalised due to infection. Antibiotics are critical to treat them.
Moreover, the growth of drug-resistant bacteria is undermining the key advances that have been made in surgery, radiotherapy and immunotherapies, as treatment is delayed or stopped to treat rising infections.
Malin Grape is Sweden’s – and the world’s – first Ambassador on AMR, working to counteract AMR and its consequences in the EU and internationally. She joins us for this episode of “Let’s Talk Cancer” ahead of the upcoming UN high-level meeting in September on AMR.
Hosted on Acast. See acast.com/privacy for more information.
-
Episodes manquant?
-
The past few decades have witnessed significant strides in how cancer is detected, diagnosed and treated, leading to a noticeable decrease in mortality rates in many countries.
These improvements are largely due to new discoveries about why and how cancer develops, generating new ways of treating cancer to help people live longer, healthier lives.
From immunotherapy and AI to cancer vaccines - Cary Adams, CEO of UICC speaks with Dr Laszlo Radvanyi, President and Scientific Director of the Ontario Institute for Cancer Research, an internationally renowned research institute located in Toronto, Canada, who is at the forefront of some of the most ground-breaking work in cancer research.
Hosted on Acast. See acast.com/privacy for more information.
-
Around 8 million people die because of tobacco consumption every single year, leading the tobacco industry to search for new users. Increasingly, it is targeting youth in the hope of hooking a new generation to tobacco products and creating lifelong consumers. To protect youth from tobacco industry interference, we must ensure that their perspectives are heard.
In this episode of Let’s Talk Cancer, Cary Adams, CEO of UICC speaks with Agamroop Kaur, National Youth Advocate of the Year of the Campaign for Tobacco-Free Kids and David Planas Maluenda, global health policymaker at the Spanish Association Against Cancer in Zaragoza and Youth Ambassador Against Cancer at the European Cancer Leagues.
Hosted on Acast. See acast.com/privacy for more information.
-
Diagnosed with Stage 3 brain cancer and given a few years to live, Iain Ward has made it his life goal to break the world record for the most money raised for charity running a marathon. Listen to his unique story of purpose and perseverance, as we discuss everything from his innovative use of social media as a fundraising tool, to the importance of mental health and cancer.
Hosted on Acast. See acast.com/privacy for more information.
-
WHO has released new global cancer figures, showing stark inequities in preventing and treating cancer, with rising numbers of cases and cancer-related deaths expected to affect the countries least equipped to cope.
In this episode of "Let's Talk Cancer", Isabelle Soerjomataram, researcher and epidemiologist at the International Agency for Research on Cancer, WHO's cancer branch, analyses and interprets these global cancer trends.
Hosted on Acast. See acast.com/privacy for more information.
-
James Auste's experience with a brain tumour and inadequate treatment options in the Philippines inspired the creation of Cancer Warriors Philippines to support those unable to afford care. As CEO of the organisaiton, his mother Carmen Auste continues to advocate for equitable cancer treatment and systemic health reforms in the country.
In this episode, Carmen Auste discusses her leadership in cancer advocacy, exploring ways to empower people with lived experience and influence healthcare policy by steering policymakers toward prioritising cancer care.
Hosted on Acast. See acast.com/privacy for more information.
-
When Soma Ghosh was diagnosed with cancer in August 2016, she was 41 years old and given just 6 months to live by one of India’s leading oncologists. Her family moved countries - from India to the United States in search of the best treatment in the world, consulted several doctors, and changed schools and jobs. Soma passed away in December last year, 6 and a half years later.
Sukanti Ghosh, her husband, joins us today to discuss this chapter of their lives - his role as a caregiver, the toll taken by cancer on their family, the critical importance of a supportive caregiving framework of employers, family and friends - and the fact that he believes there is a role for him to play in celebrating Soma’s cancer journey.
Hosted on Acast. See acast.com/privacy for more information.
-
Drug resistance is one of the most serious health threats facing humanity. Bacteria, fungi, viruses, and parasites are learning more and more to resist the medicines that are meant to kill them. These 'superbugs' can spread easily, increasing the risk of prolonged illness, or even death, from common infections. And the danger for cancer patients is particularly high. One of the reasons is the overuse and misuse of antimicrobial medicines.
By 2050, Antimicrobial Resistance (AMR) could cause 10 million deaths per year and cost more than USD 100 trillion to public health - if no action is taken.
On the occasion of World Antimicrobial Awareness Week from 18-23 November, Cary Adams, UICC’s CEO speaks with Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance and former Chief Medical Officer for England.Cary Adams, UICC’s CEO speaks with Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance and former Chief Medical Officer for England.
Hosted on Acast. See acast.com/privacy for more information.
-
Millions of people around the world are living and dying in terrible and preventable pain.
Pain is unfortunately a common symptom in many types of cancer, or a side effect of cancer treatments such as chemotherapy or radiation. However, the production and distribution of medicines, such as morphine, tend to be heavily regulated. The burden is unevenly shared. 50% of the world’s poorest populations live in countries that receive only 1% of the opioid pain relief medicines distributed worldwide.
This episode of Let's Talk Cancer explores the pain relief divide with Elizabeth Saenz, from the United Nations Office on Drugs and Crime (UNODC) and Michel Kazatchkine, former Executive Director of the Global Fund and a member of the Global Commission on Drug Policy, a group of high-level personalities who advocate for the strict legal regulation of psychoactive substances.
Hosted on Acast. See acast.com/privacy for more information.
-
Space offers unique opportunities for scientific exploration, including cancer research. Dr Peggy Whitson, America’s most experienced astronaut, and Dr Catriona Jamieson, Director of Sanford Stem Cell Institute, join us to discuss the “Cancer in low-Earth orbit” project. Tune in to find out how discoveries in space can help save lives on earth.
Hosted on Acast. See acast.com/privacy for more information.
-
Half the world's population still lacks access to essential health services, including cancer care. Universal health coverage is key in changing this.
Senator Dr Sania Nishtar, former Federal Minister of Health of Pakistan, provides insights into the often-overlooked issue of integrating comprehensive cancer services into national health benefits packages and the challenges faced by governments in achieving this goal.
Hosted on Acast. See acast.com/privacy for more information.
-
Attempts to cure cancer have spanned centuries and been influenced by culture, region and religion. Those working to understand and treat cancer have faced similar problems throughout history.
Thanks to modern medicine, we are constantly seeing better survival rates. Yet cancer remains a leading cause of death worldwide. Looking at the past can provide valuable lessons in understanding cancer and managing innovation.
In this episode, Cary Adams, CEO of UICC, speaks with Professor Yolanda Eraso, from London Metropolitan University, and with Carsten Timmermann, from the University of Manchester.
Hosted on Acast. See acast.com/privacy for more information.
-
Black, Indigenous and People of Colour face healthcare disparities in many forms, including in their experience of cancer. The reasons are complex and involve numerous economic, social and biological factors.
This was the experience of Michelle Audoin, a Black woman diagnosed with metastatic breast cancer at age 40. Asked to decide whether or not she wanted reconstructive breast surgery, she could find no images of Black women to help her make an informed choice.
With the aim of raising awareness of the experiences of Black, Indigenous and People of Colour living with breast cancer, Michelle came up with the idea of Uncovered, A Breast Recognition Project, a resource created in collaboration with ReThink Breast Cancer, an organisation based in Canada.
Through powerful photographs and stories of BIPOC living with breast cancer, Uncovered seeks to shine a light on these inequities, and help educate all people about the unmet needs of the Black, Indigenous and People of Colour community.
We're speaking with Michelle Audoin, the creator of Uncovered, and MJ DeCoteau, Founder and Executive Director of Rethink Breast Cancer.
Hosted on Acast. See acast.com/privacy for more information.
-
A staggering 99% of the population is breathing air that exceeds safe quality limits set by the World Health Organization (WHO). This polluted air, filled with fine particulate matter from various sources like fossil fuel combustion, wildfires, and construction sites, poses significant health risks – notably, an increased risk of cancer.
This episode of "Let's talk cancer" delves into this public health crisis with Dr Maria Neira, Director of Public Health, Environmental and Social Determinants of Health at WHO.
Hosted on Acast. See acast.com/privacy for more information.
-
Drug shortages - from antibiotics to vital cancer drugs - have grown into a global concern, and the unavailability of these medicines hits lower-income countries hardest. In this episode of Let's talk cancer, Cary Adams together with Hans Hogerzeil, formerly of WHO, and Charles Gore of Medicines Patent Pool, explains the reasons behind this, and ways to ensure that everyone receives the medicines they need, when they need them.
Hosted on Acast. See acast.com/privacy for more information.
-
Fake science, front groups and the promise of happiness: uncover the tactics used by the tobacco and alcohol industries to market their products, particularly to vulnerable populations, as well as ways to counter them.
In this podcast, Cary Adams, CEO of UICC, is joined by Dr Adriana Blanco Marquizo, Head of the Secretariat of the WHO Framework Convention on Tobacco Control, and Maik Dunnbier, Director of Strategy and Advocacy at Movendi International.
Hosted on Acast. See acast.com/privacy for more information.
-
Around 13% of adults are considered obese and 40% overweight. Once a concern only for high-income countries, excess body weight now affects people across different regions and income levels and has become one of the world’s biggest public health concerns.
Excess body weight is a risk factor for many diseases including more than a dozen types of cancer.
But too often, individuals are seen as solely responsible for their weight, and people who “obese” or “overweight” – who have a high body mass index – are stigmatised if not discriminated against. They are told to simply “eat less” and “exercise more”, and made to feel responsible for their poor health, when in truth, the reasons are complex and numerous, ranging from genetics to a low socioeconomic background and a lack of opportunity to make informed choices about their health. Many people also live in environments where healthy foods and the ability to exercise are less available, accessible or affordable.
In this podcast, Cary Adams, CEO of UICC, speaks with Fiona Bull, Head of Physical Activity at the Department of Health Promotion, at the World Health Organization, and Kendra Chow, Policy and Public Affairs Manager at the World Cancer Research Fund International, and a registered dietician, about the world’s obesity and nutrition problem.
Hosted on Acast. See acast.com/privacy for more information.
-
Did you know that the LGBTQI community may face a higher risk of cancer than those who identify as heterosexual?
Discrimination can have a significant impact on the health of LGBTQI individuals. Coping with stigma and marginalisation can lead to unhealthy behaviours, such as drinking and smoking, which can contribute to an increased risk of cancer. And negative experiences in healthcare can lead to delayed in diagnosis and treatment.
In the latest episode, Mandi Pratt-Chapman from the George Washington Cancer Center sheds light on the microaggressions and other barriers faced by LGBTQI community in accessing cancer services.
Hosted on Acast. See acast.com/privacy for more information.
-
A highly promising field in cancer research is the development of blood tests that can detect different cancers at the earliest stages. Referred to as multi-cancer early detection (MCED), this technology has the potential to become a game-changer for cancer control worldwide. Dr Dan Milner, Executive Director of the Access to Oncology Medicines Coalition (ATOM) explains how MCED works and why he is optimistic that it will help us turn the tide on cancer.
Hosted on Acast. See acast.com/privacy for more information.
- Montre plus
